NVS

Q: What is the price of Novartis (NVS) today?

The price of Novartis (NVS) today is R$ 686,39, with a variation of 9.48% compared to the last year. The price of Novartis (NVS) started the year trading around R$ 0,00 and today it is at R$ 686,39. Follow the real-time price chart, the historical price of Novartis (NVS), and stock data from Ibovespa and international markets.

Q: When does Novartis (NVS) pay dividends?

In the last year, Novartis (NVS) distributed dividends in the month of April, totaling R$ 20,47. The Dividend Yield for the last 12 months is 3,05%.

Q: Novartis (NVS) is it worth it?

Currently, Novartis (NVS) is priced at R$ 686,39, with a P/E of 18,12%, representing a deviation of 24,70% from its historical average P/E. In the last year, the stock showed a variation of 9.48% in its price and distributed R$ 20,47 in dividends, resulting in a Dividend Yield of 3,05%. The total shareholder return was 9,48%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy shares of Novartis (NVS)?

Investing in shares of Novartis (NVS) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 shares of Novartis (NVS) yield today?

The yield of Novartis (NVS) was 7,60% in the last month, 9,48% in the last year and 90,13% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of R$ 20,97 in dividends, um Dividend Yield de 3,05%.If you wanted to buy 100 shares of Novartis (NVS) today, the total investment would be based on the current price of R$ 686,39.If past performance were to repeat, the return on your investment would be:In 1 year: R$ 75.145,85In 5 years: R$ 130.503,10In 10 years: 142.933,60It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Novartis AG

Price

US$ 126,64

variation (12m)

9,48%

p/l

18,12

p/vp

5,88

DIVIDEND YIELD

3,05%

quote NVS

BVMF

NVS

If you had invested

year ago

6 months

1 year

5 years

10 years

today you would have

today you would have:

*The figure considers the reinvestment of dividends.

profitability of NVS

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

7,60%

3 months

13,20%

1 year

9,48%

2 years

40,76%

5 years

90,13%

10 years

108,24%

real profitability

profitability minus inflation.

1 month

7,60%

3 months

12,64%

1 year

4,02%

2 years

28,31%

5 years

38,93%

10 years

23,45%

Indicators NVS

check out the fundamentals of Novartis shares

P/L

18,12

Sector: -1,52 Industry: -3,80

P/SALES (PSR)

4,48

Sector: 1,99 Industry: 2,90

P/VP

5,88

Sector: 2,16 Industry: 1,76

DIVIDEND YIELD (DY)

3,05%

Sector: - Industry: -

ROA

13,08%

Sector: -26,53% Industry: -56,94%

ROE

32,47%

Sector: -31,21% Industry: -45,34%

ROIC

17,07%

Sector: -404,40% Industry: -420,46%

Net Margin

24,74%

Sector: -26,56% Industry: -32,35%

GROSS MARGIN

76,25%

Sector: 44,49% Industry: 44,86%

OPERATING MARGIN

30,23%

Sector: -23,10% Industry: -30,21%

P/EBITDA

10,89

Sector: 0,07 Industry: -2,60

P/EBIT

14,81

Sector: -1,37 Industry: -3,22

P/ASSETS

2,37

Sector: 1,23 Industry: 1,32

VPA

21,59

Sector: 3,66 Industry: 1,68

LPA

7,01

Sector: -0,80 Industry: -1,22

EQUITY / ASSETS

0,40

Sector: 0,45 Industry: 0,48

CAGR REVENUES 5 YEARS

2,03%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

11,09%

Sector: - Industry: -

FAIR PRICE OF Novartis ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 126,64

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

-53,92%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

NVS indicators history

DRAG THE FRAME TO SEE MORE DATA

comparator of Stocks

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	Net Margin
LLY	45,25	34,03	75,21%	0,81%	US$ 624,41 B	25,91%
ISRG	65,56	9,52	14,52%	0,00%	US$ 170,94 B	28,51%
TMO	28,71	3,73	13,01%	0,33%	US$ 189,00 B	15,24%
MDT	25,50	0,00	0,00%	3,03%	US$ 118,85 B	13,63%
SNY	11,17	1,55	13,90%	4,31%	US$ 125,86 B	14,83%
CVS	19,92	1,16	5,84%	3,73%	US$ 90,27 B	1,17%
GSK	17,94	4,15	23,12%	4,04%	US$ 80,77 B	10,87%
ABT	15,66	4,31	27,50%	1,81%	US$ 218,97 B	32,43%
TMDX	56,86	12,81	22,53%	0,00%	US$ 4,07 B	13,49%
HCA	16,35	-78,84	-482,31%	0,68%	US$ 97,60 B	8,21%
BSX	62,73	6,94	11,06%	0,00%	US$ 157,13 B	13,54%
INMD	5,22	1,48	28,44%	0,00%	US$ 933,03 M	44,50%
DHR	44,49	2,90	6,52%	0,56%	US$ 151,86 B	14,21%
IDXX	52,40	35,40	67,57%	0,00%	US$ 51,64 B	24,41%
FMS	20,59	0,91	4,42%	3,07%	US$ 15,03 B	3,41%
HUM	23,00	1,98	8,61%	1,18%	US$ 36,24 B	1,28%
PHG	127,59	2,23	1,75%	3,13%	US$ 26,81 B	1,07%
DXCM	56,42	12,53	22,21%	0,00%	US$ 32,25 B	13,29%
RMD	30,62	7,19	23,47%	0,72%	US$ 42,88 B	27,22%

comparison of NVS with indexes

If you had invested (change) 2 years a year ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

dividend history NVS dividend history

Current DY: 3,05%

5-year average DY: 4,22%

DRAG THE FRAME TO SEE MORE DATA

type	date with	payment date	value
Dividends	12/03/2025	25/04/2025	3,86950000
Dividends	08/03/2024	19/04/2024	3,77700000
Dividends	10/03/2023	20/03/2023	3,46900000
Dividends	09/03/2022	17/03/2022	3,32530000
Dividends	05/03/2021	15/03/2021	3,37800000
Dividends	04/03/2020	12/03/2020	3,04200000
Dividends	05/03/2019	13/03/2019	2,86500000
Dividends	07/03/2018	25/04/2018	2,97700000
Dividends	03/03/2017	20/04/2017	2,74600000
Dividends	26/02/2016	15/04/2016	2,76200000
Dividends	04/03/2015	20/04/2015	2,81700000
Dividends	03/03/2014	10/04/2014	2,71900000
Dividends	28/02/2013	05/04/2013	2,53000000
Dividends	29/02/2012	05/04/2012	2,46000000
Dividends	28/02/2011	08/04/2011	2,35300000
Dividends	04/03/2010	13/04/2010	1,98700000
Dividends	26/02/2009	06/04/2009	1,72000000
Dividends	28/02/2008	11/04/2008	1,47200000
Dividends	08/03/2007	10/04/2007	1,08100000
Dividends	02/03/2006	03/04/2006	0,89400000
Dividends	03/03/2005	06/04/2005	0,98570000
Dividends	26/02/2004	30/03/2004	0,80600000
Dividends	06/03/2003	07/04/2003	0,70000000
Dividends	25/03/2002	22/04/2002	0,52200000
Dividends	26/03/2001	20/04/2001	0,50200000

ABOUT THE COMPANY Novartis

Novartis AG

Average user rating I10

4.0 (54 people)

Estados Unidos

29 years

Foundation: 1996

1996

Year of debut on the stock exchange - 29 years

105.794

Employees

The Company Novartis AG (Estados Unidos), is listed on NYSE with a market value of $ 247,36 Billions, having a net worth of $ 42,05 Billions.

With a total of 105.794 employees, the company is listed in the sector of Saúde and categorized in industry of Principais Medicamentos.

In the last 12 months the Company had a revenue of $ 55,19 Billions, which generated a profit in the amount of $ 13,65 Billions.

As for its main indicators, the Company has a P/E ratio of 18,12, a P/B ratio of 5,88 and in the last 12 months the dividend yield of NVS was at 3,05%.

The Company is traded in Brazil through the BDR N1VS34, or can be purchased on abroad through the ticker NVS.

Market value

US$ 247,36 Billions

Net worth

US$ 42,05 Billions

US$ 42.054.000.000,00

Assets

US$ 104,40 Billions

US$ 104.395.000.000,00

Total Number of Shares

1,95 Billion

1.948.000.000

Average Daily Trading Volume

US$ 1,66 Million

US$ 1.657.042,00

Sector

Saúde

Industry

Principais Medicamentos

NVS

NVS revenue and profits

NVS results

DRAG THE FRAME TO SEE MORE DATA

NVS cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

LBPSW - 4D pharma

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 71,55 30,23% (12M)

P/L

19,92

3,73%

ROE

5,84%

P/VP

1,16

CI - Cigna

US$ 300,32 --13,19% (12M)

P/L

16,13

1,91%

ROE

12,41%

P/VP

2,00

CNC - Centene

US$ 28,66 --63,26% (12M)

P/L

7,07

0,00%

ROE

7,47%

P/VP

0,53

HUM - Humana

US$ 298,87 --14,32% (12M)

P/L

23,00

1,18%

ROE

8,61%

P/VP

1,98

SNY - Sanofi

US$ 50,30 --6,73% (12M)

P/L

11,17

4,31%

ROE

13,90%

P/VP

1,55

HCA - HCA Healthcare

US$ 401,96 4,05% (12M)

P/L

16,35

0,68%

ROE

-482,31%

P/VP

-78,84

LLY - Eli Lilly

US$ 736,03 --22,19% (12M)

P/L

45,25

0,81%

ROE

75,21%

P/VP

34,03

LBPSW - 4D pharma

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 71,55 30,23% (12 M)

P/L

19,92

3,73%

ROE

5,84%

P/VP

1,16

CI - Cigna

US$ 300,32 --13,19% (12 M)

P/L

16,13

1,91%

ROE

12,41%

P/VP

2,00

CNC - Centene

US$ 28,66 --63,26% (12 M)

P/L

7,07

0,00%

ROE

7,47%

P/VP

0,53

HUM - Humana

US$ 298,87 --14,32% (12 M)

P/L

23,00

1,18%

ROE

8,61%

P/VP

1,98

SNY - Sanofi

US$ 50,30 --6,73% (12 M)

P/L

11,17

4,31%

ROE

13,90%

P/VP

1,55

HCA - HCA Healthcare

US$ 401,96 4,05% (12 M)

P/L

16,35

0,68%

ROE

-482,31%

P/VP

-78,84

LLY - Eli Lilly

US$ 736,03 --22,19% (12 M)

P/L

45,25

0,81%

ROE

75,21%

P/VP

34,03

Common Questions

What is the price of Novartis (NVS) today?

The price of Novartis (NVS) today is R$ 686,39, with a variation of 9.48% compared to the last year. The price of Novartis (NVS) started the year trading around R$ 0,00 and today it is at R$ 686,39. Follow the real-time price chart, the historical price of Novartis (NVS), and stock data from Ibovespa and international markets.

When does Novartis (NVS) pay dividends?

In the last year, Novartis (NVS) distributed dividends in the month of April, totaling R$ 20,47. The Dividend Yield for the last 12 months is 3,05%.

Novartis (NVS) is it worth it?

Currently, Novartis (NVS) is priced at R$ 686,39, with a P/E of 18,12%, representing a deviation of 24,70% from its historical average P/E. In the last year, the stock showed a variation of 9.48% in its price and distributed R$ 20,47 in dividends, resulting in a Dividend Yield of 3,05%. The total shareholder return was 9,48%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy shares of Novartis (NVS)?

Investing in shares of Novartis (NVS) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 shares of Novartis (NVS) yield today?

The yield of Novartis (NVS) was 7,60% in the last month, 9,48% in the last year and 90,13% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of R$ 20,97 in dividends, um Dividend Yield de 3,05%.

If you wanted to buy 100 shares of Novartis (NVS) today, the total investment would be based on the current price of R$ 686,39.

If past performance were to repeat, the return on your investment would be:

In 1 year: R$ 75.145,85
In 5 years: R$ 130.503,10
In 10 years: 142.933,60

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

NVS

Novartis AG

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

profitability of NVS

check out the fundamentals of Novartis shares

P/L

P/SALES (PSR)

P/VP

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

Net Margin

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSETS

VPA

LPA

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years a year ago, today you would have

Current DY: 3,05%

5-year average DY: 4,22%

type

date with

payment date

value

ABOUT THE COMPANY Novartis

Novartis AG

Estados Unidos

29 years

1996

105.794

PROFIT X PRICE NVS

NVS results

NVS cash flow

evolution of assets - NVS

NVS balance sheet

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

Common Questions

Tudo que o investidor precisa em um só lugar

Pague 2, Leve 3

Anual

Valor total R$ 238,80